Virus News and Research

Latest Virus News and Research

Scientists discover natural cellular defense mechanism against ALS progression

ALS is a disease where, in most cases, a protein forms aggregates in neurons, which leads to the rapid loss of motor control and death.

20 Oct 2026

Researchers identify molecular pathway that improves ultrasound-based bone defect healing

Researchers from Capital Medical University, Beijing, China, have identified a CaN/NFATC3/Id3/E2A/Bmp4 signaling pathway that helps explain how low-intensity pulsed ultrasound (LIPUS) promotes bone regeneration.

15 Oct 2026

Breast milk antibodies show promise against multiple respiratory viruses

Yona Tugg and colleagues show that a polyclonal secretory immunoglobulin A preparation, purified from breast milk pooled from multiple donors, neutralized respiratory syncytial virus (RSV), human adenovirus type 5, and H1N1 and H3N2 influenza A viruses in laboratory assays.

14 Oct 2026

Does the type of hand sanitizer matter? A study involving 568 people suggests it might

In a 72-day randomized trial involving 568 participants in Japan, an experimental hand sanitizer containing ethanol, benzalkonium chloride, and lactic acid was associated with a 40% lower cumulative incidence of upper respiratory symptoms than a commercial ethanol-based sanitizer. Participants using the experimental formulation also experienced fewer illness-related work restrictions, although infections were not laboratory-confirmed and the proposed residual antimicrobial mechanism was not directly tested.

14 Oct 2026

Experimental gene therapy offers non-surgical option for hydrocephalus

Researchers at the University of Cincinnati College of Medicine have published the first proof-of-concept study showing the potential of an experimental gene therapy for hydrocephalus.

14 Oct 2026

Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus

The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate of 48 percent.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Mosquito saliva study opens new doors for blocking Zika, Dengue, and West Nile infections

Mosquitoes do more than simply transmit the viruses they carry: their saliva may actively help these viruses establish infection in the body from the very moment of the bite.

14 Oct 2026

Researchers improve CRISPR technology for detecting HIV and other RNA viruses

Scientists have long used a powerful gene-editing tool called CRISPR to make precise changes to DNA. But a different version of the technology, known as Cas13a, targets RNA, the genetic material found in viruses such as HIV.

13 Oct 2026

$5.8 million study explores gut-brain inflammation in people with HIV

Oregon Health & Science University researchers have secured a $5.8 million, five-year federal award to investigate whether damage to the gastrointestinal tract contributes to neuroinflammation in people living with HIV - raising the potential for new treatments to preserve brain function in people with HIV and older adults.

13 Oct 2026

Targeting the RUNX1 gene helps reduce severe skin fibrosis

Skin fibrosis includes hypertrophic scar (HTS), keloid scar (KS), and systemic sclerosis (SSc). These conditions share persistent fibroblast activation, excessive extracellular matrix (ECM) deposition, and progressive skin remodeling.

13 Oct 2026

New AI system accelerates rabies virus detection in cell cultures

Rabies virus detection in cell cultures could soon become faster and more accessible, thanks to a world-first AI system developed by researchers at the University of Surrey's Institute for People-Centred AI (PAI) in collaboration with the Rabies and Viral Zoonoses team at the Animal and Plant Health Agency (APHA).

12 Oct 2026